Trials / Completed
CompletedNCT05520840
Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to validate the value of value of peripheral blood protein biomarkers in colorectal cancer screening, and to identify new ones
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | blood sampling for screening of biomarkers | Patient aged 50 years or older referred for screening colonoscopy after a positive fecal immunochemical test or for endoscopic resection of a previously identified suspicious colorectal lesion will have a blood sampling for biomarkers detection |
Timeline
- Start date
- 2022-12-09
- Primary completion
- 2024-09-26
- Completion
- 2024-09-26
- First posted
- 2022-08-30
- Last updated
- 2026-02-06
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05520840. Inclusion in this directory is not an endorsement.